Breaching B cell tolerance in the tumor microenvironment
- PMID: 35413269
- DOI: 10.1016/j.ccell.2022.03.011
Breaching B cell tolerance in the tumor microenvironment
Abstract
The immune system employs complex tolerance mechanisms in order to avoid harmful autoimmunity, yet autoantibodies are frequently observed in cancer. In a paper in Cell, Mazor et al. report that autoantibodies produced by tumor-infiltrating B cells in human ovarian cancer frequently recognize the self-protein matrix metalloproteinase 14 (MMP14) through two distinct mechanisms of tolerance disruption.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.Cell. 2022 Mar 31;185(7):1208-1222.e21. doi: 10.1016/j.cell.2022.02.012. Epub 2022 Mar 18. Cell. 2022. PMID: 35305314
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
